Kan Xiong, Ph.D.
Group Leader, Research Scientist
Kan Xiong is a group leader in the Gerstner Center for Cancer Diagnostics at the Broad Institute of MIT and Harvard. Xiong joined the center at the end of 2017. His research has been focusing on developing both ex vivo and in vivo technologies for improving the sensitivity and specificity of liquid biopsy tests for cancer detection. In addition, Xiong works on demonstrating the utility of liquid biopsy tests in various clinical settings.
Xiong co-developed first-in-class priming agents that can slow down cell free DNA clearance and enhance the sensitivity of liquid biopsies. This work was recently reported in Science.
Xiong got his B.S. in chemistry from the University of Science and Technology of China. He then obtained his Ph.D. in chemistry from the University of Pittsburgh. His Ph.D. work mainly focused on utilizing UV Resonance Raman spectroscopy to study protein structure and protein folding. Afterwards, Xiong worked as a postdoctoral fellow in Paul Blainey's lab at Broad, developing single molecule imaging techniques and studying protein-DNA interactions at the single molecule level.
Contact Kan Xiong via email at kanxiong@broadinstitute.org.
July 2024
